Healing Touch During Chemotherapy Infusions for Women With Breast Cancer

Stanford University32 enrolled

Overview

To study if Healing Touch is effective during chemotherapy treatment for breast cancer

To study the effectiveness of Healing Touch provided during chemotherapy infusions on the experience of women undergoing treatment for breast cancer. Healing Touch (HT) is a gentle, non-invasive form of energy-balancing work that promotes relaxation and can help manage the side effects of chemotherapy.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

NONE

Enrollment

Conditions

Breast Cancer

Interventions

Healing TouchPROCEDURE

every other week (during their infusion)

Standard careOTHER

Adriamycin, cyclophosphamide, and paclitaxel administered as standard of care

guided relaxationPROCEDURE

Eligibility

Sex: FEMALEMin age: 18 YearsMax age: 70 Years

Medical Language ↔ Plain English

Inclusion Criteria:- Stage I or II breast cancer * Post-operative * Concurrent enrollment on a treatment protocol of 8 weeks of adriamycin + cyclophosphamide given every other week followed by 8 weeks of paclitaxel given every other week * ECOG Performance Status: 0 to 2 * Speak and read English Exclusion Criteria:- Previous chemotherapy exposure \- Concomitant energy-work interventions (HT, Reiki, QiGong, acupuncture).

Locations (1)

Stanford University School of Medicine

Stanford, California, United States

Outcomes

Primary Outcomes

FACT-B summary score

Time frame: Baseline, 6 wks, 14 wks

Secondary Outcomes

Domain scores for FACT-B; BSI-18; FACIT-Fatigue; nausea measured on a Likert scale

Time frame: Baseline, 6 wks, 14 wks

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.